CA1050996A - Antidiabetic agent, "isoxazole derivatives" - Google Patents

Antidiabetic agent, "isoxazole derivatives"

Info

Publication number
CA1050996A
CA1050996A CA255,153A CA255153A CA1050996A CA 1050996 A CA1050996 A CA 1050996A CA 255153 A CA255153 A CA 255153A CA 1050996 A CA1050996 A CA 1050996A
Authority
CA
Canada
Prior art keywords
methylisoxazole
compound
compounds
carboxamide
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA255,153A
Other languages
English (en)
French (fr)
Inventor
Tsutomu Irikura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of CA1050996A publication Critical patent/CA1050996A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA255,153A 1975-06-21 1976-06-17 Antidiabetic agent, "isoxazole derivatives" Expired CA1050996A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50076176A JPS52264A (en) 1975-06-21 1975-06-21 Process for preparing novel isoxazole derivatives

Publications (1)

Publication Number Publication Date
CA1050996A true CA1050996A (en) 1979-03-20

Family

ID=13597782

Family Applications (1)

Application Number Title Priority Date Filing Date
CA255,153A Expired CA1050996A (en) 1975-06-21 1976-06-17 Antidiabetic agent, "isoxazole derivatives"

Country Status (13)

Country Link
US (1) US4026902A (enExample)
JP (1) JPS52264A (enExample)
AR (1) AR209492A1 (enExample)
AU (1) AU497558B2 (enExample)
BE (1) BE843195A (enExample)
CA (1) CA1050996A (enExample)
DE (1) DE2627696A1 (enExample)
ES (1) ES449068A1 (enExample)
FR (1) FR2315923A1 (enExample)
GB (1) GB1529403A (enExample)
SE (1) SE428688B (enExample)
SU (1) SU584774A3 (enExample)
ZA (1) ZA763356B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196046A (en) * 1984-07-26 1993-03-23 Rohm And Haas Company N-acetonyl-substituted-amides
US4863940A (en) * 1984-07-26 1989-09-05 Rohm And Haas N-acetonyl-substituted amides and phytopathogenic fungicidal use thereof
US4717064A (en) * 1986-08-15 1988-01-05 Unisys Corporation Wave solder finger shield apparatus
US5258397A (en) * 1988-11-30 1993-11-02 Novapharme 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
FR2662692B1 (fr) * 1990-05-30 1995-04-28 Novapharme Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
FR2639636B1 (fr) * 1988-11-30 1994-03-04 Novapharme Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
US4930204A (en) * 1989-02-01 1990-06-05 A. O. Smith Corporation Method of forming composite tubular structure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073284B1 (enExample) * 1969-12-23 1973-07-13 Ferlux

Also Published As

Publication number Publication date
FR2315923A1 (fr) 1977-01-28
DE2627696A1 (de) 1977-01-13
BE843195A (fr) 1976-10-18
GB1529403A (en) 1978-10-18
JPS5314067B2 (enExample) 1978-05-15
FR2315923B1 (enExample) 1979-09-21
AU1459376A (en) 1977-12-08
AU497558B2 (en) 1978-12-14
SU584774A3 (ru) 1977-12-15
ZA763356B (en) 1977-05-25
AR209492A1 (es) 1977-04-29
SE428688B (sv) 1983-07-18
JPS52264A (en) 1977-01-05
US4026902A (en) 1977-05-31
SE7607038L (sv) 1976-12-22
ES449068A1 (es) 1977-07-16

Similar Documents

Publication Publication Date Title
EP0196222B1 (en) Hypoglycemic agent
US4072759A (en) Novel benzylalcohol derivatives as antidiabetics and cardiotonics
US3987177A (en) Vincaminic acid esters
LU79761A1 (fr) Procede de preparation de nouveaux composes de phtalazine et de composition pharmaceutique les contenant
US5354760A (en) Crystalline Tiagabine monohydrate, its preparation and use
CA1050996A (en) Antidiabetic agent, "isoxazole derivatives"
DE1695677B1 (de) N-Arylsulfonyl-N'-(3-aza-bicycloalkyl)-harnstoffe,ihre Salze und Verfahren zu ihrer Herstellung
FR2516083A1 (fr) Derives de l'ergoline, procede pour leur preparation et medicaments les contenant
US4220648A (en) Antidiabetic 1,2-dihydro-2-oxo-6-neopentyl-nicotinic acids
US4728739A (en) Hypoglycemic thiazolidinediones
EP0009608B1 (en) N-phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them
KR950006866B1 (ko) 에르골린 에스테르의 제조방법
US4764623A (en) N-(1H-tetrazol-5-yl-alkylphenyl)polyfluoroalkanamides
EP0401262B1 (en) 24r-scymnol, and preparation and use thereof
US2949464A (en) 3-amino-5-(para-hydroxy-benzylidene) rhodanine
US4567192A (en) Acylaminophenol derivatives
JPH03167184A (ja) Ｎ―ベンジルトロパンアミド類
CA1188705A (en) Cystine derivatives
US4218479A (en) Novel benzylalcohols and pharmaceutical compositions and use thereof
US3393240A (en) 7-oxo-7-desacetylamino-colchicine compounds
US4092322A (en) 1-Benzoxepino[4,3-c]pyridines
US4288440A (en) Pyridinones
US4070468A (en) 2-Amino-quinolin-4-one-3-phosphonic acid esters
US2723273A (en) 1-gamma-glutamyl-2 isonicotinoyl hydrazines
US3884954A (en) 12-Cyano-5,6,7,12-tetrahydrodibenzo{8 a,d{9 cyclooctenes